1
/
의
1
Elabscience
SKU(재고 관리 코드):E-CL-H0473
Human MUC1(Mucin 1) CLIA Kit
Human MUC1(Mucin 1) CLIA Kit
The Human MUC1 (Mucin 1) CLIA Kit is designed to provide researchers and clinicians with a highly reliable and accurate diagnostic tool for the detection and quantification of MUC1 in human serum, plasma, and cell culture supernatants. MUC1 is a glycoprotein that is overexpressed in various diseases, including cancer, making it an important biomarker for diagnosis and monitoring of these conditions.
The kit utilizes a Chemiluminescent Immunoassay (CLIA) technique, which offers superior sensitivity and specificity compared to traditional ELISA methods. CLIA is a highly sensitive detection method that uses chemiluminescent molecules to produce light signals in response to the binding of specific antibodies to the target antigen. This allows for the detection and quantification of MUC1 with high precision and accuracy.
The Human MUC1 CLIA Kit includes all necessary reagents and components for the assay, including pre-coated plates, standards, and controls. The pre-coated plates are designed to capture MUC1 from the sample, while the standards and controls are used to generate a calibration curve and ensure the accuracy and reproducibility of the assay. This comprehensive kit eliminates the need for researchers and clinicians to source individual reagents, saving time and effort.
The assay itself is easy to perform and can be completed within a short period of time. The user simply needs to add the sample and the provided reagents to the pre-coated plates, incubate, and then wash away any unbound substances. The chemiluminescent signal is then detected using a luminometer, and the concentration of MUC1 in the sample can be determined by comparing the signal to the calibration curve generated from the standards.
The Human MUC1 CLIA Kit is an essential tool for researchers and clinicians involved in the study and diagnosis of various diseases, particularly cancer, where MUC1 expression is known to be altered. By accurately quantifying MUC1 levels, this kit can aid in the early detection, prognosis, and monitoring of cancer, as well as other diseases where MUC1 is implicated.
The kit is manufactured to the highest quality standards, ensuring consistent and reliable results. It has undergone extensive validation to ensure accuracy and reproducibility, giving researchers and clinicians confidence in the data generated. The use of this kit can contribute to advancements in the understanding and treatment of diseases associated with MUC1, ultimately leading to improved patient outcomes.
The kit utilizes a Chemiluminescent Immunoassay (CLIA) technique, which offers superior sensitivity and specificity compared to traditional ELISA methods. CLIA is a highly sensitive detection method that uses chemiluminescent molecules to produce light signals in response to the binding of specific antibodies to the target antigen. This allows for the detection and quantification of MUC1 with high precision and accuracy.
The Human MUC1 CLIA Kit includes all necessary reagents and components for the assay, including pre-coated plates, standards, and controls. The pre-coated plates are designed to capture MUC1 from the sample, while the standards and controls are used to generate a calibration curve and ensure the accuracy and reproducibility of the assay. This comprehensive kit eliminates the need for researchers and clinicians to source individual reagents, saving time and effort.
The assay itself is easy to perform and can be completed within a short period of time. The user simply needs to add the sample and the provided reagents to the pre-coated plates, incubate, and then wash away any unbound substances. The chemiluminescent signal is then detected using a luminometer, and the concentration of MUC1 in the sample can be determined by comparing the signal to the calibration curve generated from the standards.
The Human MUC1 CLIA Kit is an essential tool for researchers and clinicians involved in the study and diagnosis of various diseases, particularly cancer, where MUC1 expression is known to be altered. By accurately quantifying MUC1 levels, this kit can aid in the early detection, prognosis, and monitoring of cancer, as well as other diseases where MUC1 is implicated.
The kit is manufactured to the highest quality standards, ensuring consistent and reliable results. It has undergone extensive validation to ensure accuracy and reproducibility, giving researchers and clinicians confidence in the data generated. The use of this kit can contribute to advancements in the understanding and treatment of diseases associated with MUC1, ultimately leading to improved patient outcomes.
Share
